BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4053811)

  • 1. [Angio-immunoblastic lymphadenopathy: analysis of 70 cases].
    Liu XL; Su NS; Chen YH
    Zhonghua Nei Ke Za Zhi; 1985 Aug; 24(8):472-5, 510. PubMed ID: 4053811
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angio-immunoblastic lymphadenopathy].
    Struyf NJ; Verhelst JA; Convens CG; Beelaerts WJ; Mathijs RJ; Mahler C
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1516-8. PubMed ID: 8366940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
    Tsujisaki M; Nakahara S; Kazama Y; Shimizu H; Yoshimoto M; Takahashi T; Okada Y; Sasaki S; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Dec; 25(6):452-7. PubMed ID: 12630426
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
    Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
    Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
    Lin KW; Lee YS; Phipps C
    Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis.
    Castillo JJ; Sinclair N; Stachurski D; Jacobsen ED
    Am J Hematol; 2011 Aug; 86(8):690-3. PubMed ID: 21630306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reactive histiocytosis complicated with immunoblastic lymphadenopathy].
    Natori H; Tanaka K; Egami K; Nakamuru E; Kaji M; Motoori T
    Rinsho Ketsueki; 1984 Mar; 25(3):359-64. PubMed ID: 6547985
    [No Abstract]   [Full Text] [Related]  

  • 8. B-immunoblastic lymphoma arising in angioimmunoblastic lymphadenopathy.
    Pirker R; Schwarzmeier JD; Radaszkiewicz T; Lenzhofer R; Konrad K; Bettelheim P; Bauer K; Prischl F
    Acta Haematol; 1986; 75(2):105-9. PubMed ID: 3090816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angio-immunoblastic lymphadenopathy].
    Schmidt CG
    Dtsch Med Wochenschr; 1978 Sep; 103(39):1504. PubMed ID: 688889
    [No Abstract]   [Full Text] [Related]  

  • 10. Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: simultaneous clinical improvement with chemotherapy.
    Anzai T; Hirose W; Nakane H; Kawagoe M; Kawai T; Watanabe K
    Jpn J Clin Oncol; 1994 Apr; 24(2):106-10. PubMed ID: 8158857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
    Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.
    De Samblanx H; Verhoef G; Zachée P; Vandenberghe P
    Ann Hematol; 2004 Jul; 83(7):455-9. PubMed ID: 15034757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioimmunoblastic lymphadenopathy: an etiology for gastrointestinal lymphomatous polyposis.
    Goenka MK; Vaiphei K; Nagi B; Sriram PV; Joshi K; Kochhar R
    Am J Gastroenterol; 1996 Jun; 91(6):1236-8. PubMed ID: 8651178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lung in immunoblastic lymphadenopathy.
    Bradley SL; Dines DE; Banks PM; Hill RW
    Chest; 1981 Sep; 80(3):312-8. PubMed ID: 7273880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.
    Ong ST; Koeppen H; Larson RA; Olopade OI
    Blood; 1996 Sep; 88(6):2354-5. PubMed ID: 8822958
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and management of angio-immunoblastic lymphadenopathy.
    Newcom SR
    Int J Dermatol; 1980 Jun; 19(5):255-6. PubMed ID: 7390689
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunoblastic lymphadenopathy: study of 12 cases].
    Montserrat E; Estruch R; Urbano-Márquez A; Grau JM; Ribera JM; Rozman C
    Med Clin (Barc); 1983 May; 80(18):775-9. PubMed ID: 6633020
    [No Abstract]   [Full Text] [Related]  

  • 18. Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy.
    Melato M; Falconieri G; Giammarini Barsanti A; Mottola A
    Haematologica; 1983; 68(5):675-9. PubMed ID: 6416946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia].
    Mizobe T; Tsukada J; Higashi T; Iwashige A; Ota T; Kawano I; Kubota A; Matsuura A; Morimoto H; Ogawa R; Toda Y; Tanaka Y
    Rinsho Ketsueki; 2005 Mar; 46(3):211-6. PubMed ID: 16447717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.